Halofantrine Safety, Tolerance and Metabolism Studies.
Final rept. 26 Jun 95-30 Jun 97
FOOD AND DRUG ADMINISTRATION ROCKVILLE MD
Pagination or Media Count:
Halofantrine HCl is an antimalarial drug approved by the FDA for the treatment of mild to moderate malaria caused by Plasm odium falciparum or Plasm odium vivax1. The present study was designed to investigate the safety, tolerance and pharmacokinetics of halofantrine HCl given in multiple doses in a Phase I study as part of the overall development of halofantrine as a prophylactic antimalarial drug.